Wheezing clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Daily OM-85 in Young Children with Recurrent Wheezing

    open to eligible people ages 6 months to 72 months

    This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing

    at UCSF

  • Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

    Sorry, in progress, not accepting new patients

    The primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a three year observation period off therapy.

    at UCSF

Last updated: